Similar articles

• Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients.

  Suciu-Foca N, Ho E, King DW, Yu YP, Yu-Kai S, Reed E, Cohen D, Brensilver JM, McCabe R, Rose E, et al. Suciu-Foca N, et al. Transplant Proc. 1991 Feb;23(1 Pt 1):295-6. Transplant Proc. 1991. PMID: 1990536 No abstract available.
• Unravelling the connections between donor specific antibodies and renal allograft pathology.

  Chapman JR, Wavamunno M, O'Connell PJ, Nankivell BJ. Chapman JR, et al. Clin Transpl. 2013:361-5. Clin Transpl. 2013. PMID: 25095530
• Anti-idiotypic autoantibodies after donor-specific blood transfusions.

  Toma H, Hayasaka Y, Yasuo M, Takahashi K, Teraoka S, Ota K. Toma H, et al. Transplant Proc. 1987 Feb;19(1 Pt 1):755-7. Transplant Proc. 1987. PMID: 3274864 No abstract available.
• Vascular endothelial alloantigens in renal transplantation.

  Paul LC, Baldwin WM 3rd, van Es LA. Paul LC, et al. Transplantation. 1985 Aug;40(2):117-23. doi: 10.1097/00007890-198508000-00001. Transplantation. 1985. PMID: 3895614 Review. No abstract available.
• [Caracterization of HLA allo-immunization and clinical impact in transfusion and organ transplantation].

  Delbos F, Cesbron A. Delbos F, et al. Transfus Clin Biol. 2017 Sep;24(3):131-137. doi: 10.1016/j.tracli.2017.06.025. Epub 2017 Jul 28. Transfus Clin Biol. 2017. PMID: 28757117 Review. French.